BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 21911722)

  • 1. Nonestrogenic management of hot flashes.
    Loprinzi CL; Barton DL; Qin R
    J Clin Oncol; 2011 Oct; 29(29):3842-6. PubMed ID: 21911722
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of hot flashes in patients who have breast cancer with venlafaxine and clonidine: a randomized, double-blind, placebo-controlled trial.
    Boekhout AH; Vincent AD; Dalesio OB; van den Bosch J; Foekema-Töns JH; Adriaansz S; Sprangers S; Nuijen B; Beijnen JH; Schellens JH
    J Clin Oncol; 2011 Oct; 29(29):3862-8. PubMed ID: 21911720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Venlafaxine is superior to clonidine as treatment of hot flashes in breast cancer patients--a double-blind, randomized study.
    Loibl S; Schwedler K; von Minckwitz G; Strohmeier R; Mehta KM; Kaufmann M
    Ann Oncol; 2007 Apr; 18(4):689-93. PubMed ID: 17229772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venlafaxine versus clonidine for the treatment of hot flashes in breast cancer patients: a double-blind, randomized cross-over study.
    Buijs C; Mom CH; Willemse PH; Marike Boezen H; Maurer JM; Wymenga AN; de Jong RS; Nieboer P; de Vries EG; Mourits MJ
    Breast Cancer Res Treat; 2009 Jun; 115(3):573-80. PubMed ID: 18670875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medroxyprogesterone acetate better than venlafaxine at relieving hot flashes.
    J Support Oncol; 2005; 3(4):312. PubMed ID: 16092603
    [No Abstract]   [Full Text] [Related]  

  • 6. Nonhormonal agents show promise against hot flashes.
    Gottlieb N
    J Natl Cancer Inst; 2000 Jul; 92(14):1118-20. PubMed ID: 10904081
    [No Abstract]   [Full Text] [Related]  

  • 7. Randomized, double-blind, placebo-controlled crossover trials of venlafaxine for hot flashes after breast cancer.
    Carpenter JS; Storniolo AM; Johns S; Monahan PO; Azzouz F; Elam JL; Johnson CS; Shelton RC
    Oncologist; 2007 Jan; 12(1):124-35. PubMed ID: 17227907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [ Hot flashes and breast cancer: what to do? ].
    Aldrighi JM; Ribeiro AL; Aoki T
    Rev Assoc Med Bras (1992); 2008; 54(5):381-2. PubMed ID: 18989552
    [No Abstract]   [Full Text] [Related]  

  • 9. Venlafaxine hydrochloride for the treatment of hot flashes.
    Schober CE; Ansani NT
    Ann Pharmacother; 2003 Nov; 37(11):1703-7. PubMed ID: 14565812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer and hot flashes. Options for relief.
    Mayo Clin Health Lett; 2001 Mar; 19(3):6. PubMed ID: 11242843
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical Inquiry: Do venlafaxine and gabapentin control hot flashes in women with a history of breast cancer?
    Sarkissian A; Neher JO; Singh R; St Anna L
    J Fam Pract; 2012 Dec; 61(12):759-72. PubMed ID: 23313996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy of nonestrogenic therapy to hot flashes in cancer patients under hormone manipulation therapy: a systematic review and meta-analysis.
    Yamaguchi N; Okajima Y; Fujii T; Natori A; Kobayashi D
    J Cancer Res Clin Oncol; 2013 Oct; 139(10):1701-7. PubMed ID: 23974271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical experience with venlafaxine in the treatment of hot flushes in women with a history of breast cancer.
    van Gool AR; Bannink M; Bontenbal M; Seynaeve C
    Neth J Med; 2005 May; 63(5):175-8. PubMed ID: 15952486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venlafaxine in management of hot flashes in women with breast cancer: a systematic review and meta-analysis.
    Ramaswami R; Villarreal MD; Pitta DM; Carpenter JS; Stebbing J; Kalesan B
    Breast Cancer Res Treat; 2015 Jul; 152(2):231-7. PubMed ID: 26067931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beyond estrogen: new alternatives for the management of hot flashes.
    Dvorak SR
    S D J Med; 2002 Jan; 55(1):11-2. PubMed ID: 11808405
    [No Abstract]   [Full Text] [Related]  

  • 16. Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial.
    Loprinzi CL; Kugler JW; Sloan JA; Mailliard JA; LaVasseur BI; Barton DL; Novotny PJ; Dakhil SR; Rodger K; Rummans TA; Christensen BJ
    Lancet; 2000 Dec; 356(9247):2059-63. PubMed ID: 11145492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treating hot flashes with drugs: an update.
    Harv Womens Health Watch; 2002 Aug; 9(12):6. PubMed ID: 12370152
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of hot flashes in breast-cancer survivors.
    Loprinzi CL; Barton DL; Rhodes D
    Lancet Oncol; 2001 Apr; 2(4):199-204. PubMed ID: 11905764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized trial to assess the impact of venlafaxine and soy protein on hot flashes and quality of life in men with prostate cancer.
    Vitolins MZ; Griffin L; Tomlinson WV; Vuky J; Adams PT; Moose D; Frizzell B; Lesser GJ; Naughton M; Radford JE; Shaw EG
    J Clin Oncol; 2013 Nov; 31(32):4092-8. PubMed ID: 24081940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of hot flushes in breast cancer patients.
    Wymenga AN; Sleijfer DT
    Acta Oncol; 2002; 41(3):269-75. PubMed ID: 12195746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.